Dr. Johann Brandes MD, PHD

Expert Publications

• Alteration of pemetrexed excretion in the presence of acute renal failure and effusions: presentation of a case and review of the literature.
• Occlusive endobronchial stent placement as a novel management approach to massive hemoptysis from lung cancer.
• Cancer DNA methylation: molecular mechanisms and clinical implications.
• Targeted therapy of non-small-cell lung carcinoma.
• CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.
• Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
• Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.
• Could valproic acid be an effective anticancer agent? The evidence so far.
• Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.
• Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
• Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.

Media Releases

Get to know Oncologist Dr. Johann Brandes, who serves the population of Tennessee. Dr. Brandes is tri-certified and fellowship trained oncologist. He holds certification in Internal Medicine, Medical Oncology, and Critical Care Medicine by the American Board of Internal Medicine. Since its founding in 1936 to answer a public call to establish more uniform standards for physicians, Certification by the American Board of Internal Medicine (ABIM) has stood for the highest standard in internal medicine and its 20 subspecialties. Certification has meant that internists have demonstrated – to their peers and to the public – that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care. Dr. Brandes currently practices as an Oncologist with Tennessee Oncology, and is affiliated with St Thomas Hospital in Rutherford, Tennessee, where he holds an expertise in Thorasic Oncology. Tennessee Oncology, one of the nation’s largest, community-based cancer care specialists, is home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology’s mission remains unchanged: To provide access to high-quality cancer care and the expertise of clinical research for all patients, at convenient locations within their community and close to their home. Their growing network of physicians and locations is based on this mission. Dr. Brandes graduated with his Medical Degree from the University of Munich in Germany in 1998, giving him over two decades of experience in his field. After obtaining his Medical Degree he completed his residency with the Humboldt University Berlin in Germany. He then relocated to the United States and completed his internal medicine residency with the John Hopkins Hospital. Wanting to further his training he then completed his Medical Oncology and Pulmonary Disease and Critical Care Medicine Fellowship with the John Hopkins Hospital. To stay up to date in his field he remains a professional member of the American Society of Clinical Oncology and the American College of Chest Physicians and has been inducted as a Fellow of the American College of St Thomas. Oncology is a branch of medicine that deals with the diagnosis, treatment or prevention of cancer. The specialist who practices oncology is known as an oncologist. If an oncologist has special training in performing surgery on cancerous tumors, he or she is called a surgical oncologist. Dr. Brandes attributes his professional success to his hard work and diligence.

Recommended Articles

• How Does Ovarian Cancer Spread?

  Ovarian cancer often spreads early because it grows in the tissues that cover the ovaries and from there, it can easily spread to the bowels or abdominal lining. It can also affect other areas of the body, including the lungs or liver.A team of researchers from the University of California and the...

• Lynch Syndrome Is a Common Hereditary Cause of Ovarian Cancer

  Lynch syndrome, or hereditary non-polyposis colorectal cancer, is extremely common and is often responsible for causing ovarian cancer; however, people do not often discuss it. Now, many are trying to raise awareness and dialogue about the syndrome.Similar mutations, different awarenessMany are...

• Nausea and Vomiting as Symptoms of Colon Cancer

  The majority of people with colon cancer do not experience any symptoms during the early stages of the disease. However, there are early signs of colon cancer that we need to be aware of.Colon cancer usually starts to occur with the development of non-cancerous (benign) polyps. These polyps develop...

• New Research Targets Stage Zero Breast Cancer

  A new breast cancer diagnosis may provoke many questions. As baby boomers age, the possibility of cancer increases. Gen Xers and millennial's may also wonder about their risks, especially if breast cancer runs in the family.Receiving a diagnosis of “stage zero” breast cancer may be baffling....

• Multiple Myeloma: What is Autotransplantation?

  During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...

• Breast Cancer Survivor Raises Money to Pay Bills for Others Who Need Care

  Medical care in the United States is among one of the most expensive in the world. Even when receiving preventative care, bills can quickly rack up and become overwhelming for the average family. Imagine what happens when a terrible disease strikes.The cost of treatment deadly illnesses such as...